Cargando…

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats

Qiliqiangxin capsule (QLC), a natural herb recipe with therapeutic effect from China, has been widely used in clinical practice for attenuating cardiac remodeling induced by myocardial infarction (MI). However, the pharmacological mechanism of QLC on cardiac remodeling after MI is not entirely clear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Huiyang, Lou, Lixia, Zhang, Dongmei, Zhao, Yizhou, Zhao, Jing, Li, Chunhong, Huang, Ya, Liu, Keke, Zhao, Mingjing, Wu, Aiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437749/ https://www.ncbi.nlm.nih.gov/pubmed/31001355 http://dx.doi.org/10.1155/2019/7528214

Ejemplares similares

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015)

Wenxin Granules Influence the TGFβ-P38/JNK MAPK Signaling Pathway and Attenuate the Collagen Deposition in the Left Ventricle of Myocardial Infarction Rats
por: Huang, Ya, et al.
Publicado: (2019)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Yiqi Huoxue preserves heart function by upregulating the Sigma-1 receptor in rats with myocardial infarction
por: Lou, Lixia, et al.
Publicado: (2021)

Wenxin Granules Regulate Endoplasmic Reticulum Stress Unfolded Protein Response and Improve Ventricular Remodeling on Rats with Myocardial Infarction
por: Liu, Keke, et al.
Publicado: (2021)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Effect of Wenxin Granule on Ventricular Remodeling and Myocardial Apoptosis in Rats with Myocardial Infarction
por: Wu, Aiming, et al.
Publicado: (2013)

Advances of Traditional Chinese Medicine Regulating Connexin43 in the Prevention and Treatment of Myocardial Infarction
por: Liu, Keke, et al.
Publicado: (2021)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice
por: Ye, Yong, et al.
Publicado: (2015)

Yiqihuoxuejiedu Formula Restrains Vascular Remodeling by Reducing the Inflammation Reaction and Cx43 Expression in the Adventitia after Balloon Injury
por: Chang, Hong, et al.
Publicado: (2015)

Effect of Wenxin Granules on Gap Junction and MiR-1 in Rats with Myocardial Infarction
por: Wu, Aiming, et al.
Publicado: (2017)

miR-133: A Suppressor of Cardiac Remodeling?
por: Li, Ning, et al.
Publicado: (2018)

miRNA Expression Profile and Effect of Wenxin Granule in Rats with Ligation-Induced Myocardial Infarction
por: Wu, Aiming, et al.
Publicado: (2017)

Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2020)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
por: Lv, Meng, et al.
Publicado: (2022)

Qiliqiangxin Capsule Modulates Calcium Transients and Calcium Sparks in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Li, Yuxin, et al.
Publicado: (2022)

Bioinformatics prediction and experimental verification of a novel microRNA for myocardial fibrosis after myocardial infarction in rats
por: Guo, Qianqian, et al.
Publicado: (2023)

Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway
por: He, Yaoyao, et al.
Publicado: (2015)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure
por: Zhang, Yu, et al.
Publicado: (2019)

Qiliqiangxin attenuates hypoxia‐induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF‐1α‐dependent glycolysis
por: Wang, Yanyan, et al.
Publicado: (2018)

Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα
por: Yang, Jing, et al.
Publicado: (2016)

Upregulated lncRNA Pvt1 may be important for cardiac remodeling at the infarct border zone
por: Liu, Baihui, et al.
Publicado: (2020)

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction
por: Wang, Yanyan, et al.
Publicado: (2020)

Cardiac pericytes mediate the remodeling response to myocardial infarction
por: Quijada, Pearl, et al.
Publicado: (2023)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Wensheng, et al.
Publicado: (2023)

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Expression of Concern on “Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα”
por: PPAR Research,
Publicado: (2019)

Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
por: Leung, Alice Yeuk Lan, et al.
Publicado: (2021)

The Importance of Cardiac Biomarkers on Remodelling After Myocardial Infarction
por: Celik, Ahmet, et al.
Publicado: (2012)

Macrophage activation and polarization in post-infarction cardiac remodeling
por: Gombozhapova, Aleksandra, et al.
Publicado: (2017)

Molecular imaging of cardiac remodelling after myocardial infarction
por: Curley, Daniel, et al.
Publicado: (2018)

Biological markers and cardiac remodelling following the myocardial infarction
por: Gruzdeva, Olga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u3ogvjvb162pna1q8v0lfcu0n5